Sun Nuclear, a Mirion Medical company, will feature new and enhanced solutions for better Quality Management at the ESTRO Annual Meeting, May 3-6, in Glasgow, Scotland. The Sun Nuclear booth (#930) will highlight demonstrations and insights on the recently announced Version 5.0 of the SunCHECK® Platform, as well as advancements to the comprehensive Sun Nuclear quality management portfolio and products from other Mirion brands supporting the field of cancer care. This year’

MedBright AI Investments Inc. (the “Company” or “MedBright”) (CSE:MBAI, OTCQB:MBAIF, FSE:Y30) today announced MedMatrix, a product in which it has a significant investment, has launched two new demonstration videos highlighting the capabilities of the MedMatrix AI Reporter and Forecaster. The videos highlight the key product areas of the MedMatrix Reporter and Forecaster to provide a birds-eye view of clinic operations, including insights into market competit

BrioHealth Solutions, Inc., a medical technology company focused on developing innovative advanced heart failure solutions, today announced it has received FDA Investigational Device Exemption (IDE) approval with conditions to commence enrollment in its landmark INNOVATE trial. The study will assess the effectiveness and safety of its novel BrioVAD™ System, a magnetically levitated ventricular assist device, in treating refractory left ventricular heart failure. With the notice, BrioHea

The American Association of Kidney Patients (AAKP), the oldest and largest independent kidney patient consumer organization in the U.S., is raising public awareness on May 1, National High Potassium Awareness Day, about the devastating impacts of unmanaged potassium levels in individuals with chronic kidney disease (CKD). Nearly three million Americans with CKD and/or heart failure live with high potassium levels. Many people with CKD, including those with kidney failure, cannot pro

InterSystems, a creative data technology provider dedicated to helping customers solve the most critical scalability, interoperability and speed problems, today announced a collaboration with Consultmed, an Australian provider of a referral management and automated workflow platform connecting primary care providers, medical specialists and hospitals. As part of the collaboration, Consultmed will replatform its software on InterSystems IRIS for Health™, accelerating and reducing costs o

Caristo Diagnostics, a leading cardiac disease diagnostics company, has been named by Newsweek as one of World's Best Digital Health Companies in diagnostics. Newsweek's inaugural ranking of the World's Best Digital Health Companies includes 400 companies in seven segments including diagnostics, health records, medical management and telehealth. The ranking is based on in-depth analysis of thousands of companies' financial performance and traffic data for websites an

AriBio announced authorisation from the European Medicines Agency (EMA) for POLARIS-AD (AR1001-ADP3-US01), a global, phase 3, early Alzheimer’s disease clinical trial. EMA now aligns with the U.S. Food and Drug Administration (FDA) and UK Medicines and Healthcare Products Regulatory Agency (MHRA) on the Clinical Trial Authorisation of POLARIS-AD. The final decision from EMA was completed on April 24th with clinical trial approvals in the following member states: Czech Rep

Mangoceuticals, a company focused on developing, marketing, and selling a variety of men’s health and wellness products in the area of erectile dysfunction (ED), hair growth and hormone replacement therapies is excited to announce that it has acquired a global patent portfolio for a pioneering oral solution and application aimed to combat and prevent a spectrum of infections, including the common cold, respiratory diseases, and orally transmitted diseases such as human papillomavirus (H

BioIntelliSense, a continuous health monitoring and clinical intelligence company, announces completion of Houston Methodist’s inpatient expansion of the BioButton® continuous patient monitoring solution across all 2,653 non-ICU beds at the system’s eight hospitals. The FDA-cleared BioIntelliSense BioButton multiparameter wearable is applied to patients at the time of admission with centralized command center monitoring by Houston Methodist’s mu

Concert Health, the leading Collaborative Care platform, and the Advancing Integrated Mental Health Solutions (AIMS) Center in the University of Washington Department of Psychiatry and Behavioral Sciences, today announced a three year, multi-state project to facilitate mental health care for 2,700 patients with complex psychiatric disorders in primary care settings. Specifically, the project will leverage and scale a Telepsychiatry Collaborative Care Model (CoCM) to help identify and treat pa